Ketamine Therapy in Connecticut

Connecticut regulates ketamine therapy through a combination of federal and state-level oversight. Ketamine remains a Schedule III controlled substance under the federal Controlled Substances Act, meaning that any provider administering it must hold a valid DEA registration. At the state level, the Connecticut Department of Consumer Protection oversees the licensing of pharmacies and controlled substance dispensing, while the Connecticut Medical Examining Board governs physician licensure and standards of practice. Clinics operating in Connecticut must comply with both sets of requirements, ensuring that all practitioners who prescribe or administer ketamine hold active, unrestricted medical licenses issued by the state.

Ketamine infusion therapy in Connecticut is legally administered as an off-label use of an FDA-approved anesthetic. While the FDA has not approved ketamine specifically for the treatment of depression, chronic pain, or PTSD, physicians are permitted to prescribe approved medications for off-label purposes at their professional discretion. This means that patients seeking ketamine therapy for mental health conditions should expect a thorough intake evaluation, as responsible clinics conduct medical and psychiatric screenings to determine candidacy and minimize risk. Some Connecticut clinics work in collaboration with psychiatrists or referring mental health providers to ensure continuity of care.

With respect to telehealth and at-home ketamine, Connecticut providers must adhere to state telehealth regulations governing prescribing practices. The state has specific rules around the prescribing of controlled substances via telemedicine, generally requiring an established patient-provider relationship and, in many cases, an in-person evaluation before a controlled substance can be prescribed remotely. Patients considering at-home ketamine programs facilitated through telehealth should verify that the prescribing provider holds a valid Connecticut medical license and DEA registration. Key compliance considerations for Connecticut ketamine clinics include:

• Active DEA Schedule III controlled substance registration for all prescribing providers
• Valid Connecticut medical licensure in good standing
• Adherence to Connecticut Department of Consumer Protection controlled substance regulations
• Compliance with state telehealth prescribing standards for remote programs
• Proper recordkeeping and documentation of patient evaluations and treatment plans

Patients in Connecticut are encouraged to verify the credentials of any ketamine clinic or provider before beginning treatment. The Connecticut Medical Examining Board's public license lookup tool allows individuals to confirm a physician's licensure status. Additionally, patients should be aware that ketamine therapy for mental health and pain conditions is generally not covered by most insurance plans in Connecticut, as it remains an off-label treatment, though some providers may offer assistance with billing for associated services such as evaluations and monitoring. Staying informed about evolving state and federal regulations is important, as the legal and clinical landscape for ketamine therapy continues to develop.